Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |